Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- o r
AssigneeRhone-Poulenc Rorer S.A.
InventorsGarry Fenton, Andrew David Morley, Malcolm Norman Palfreyman, Andrew James Ratcliffe, Brian William Sharp, Keith Alfred James Stuttle, Sukanthini Thurairatnam, Bernard Yvon Jack Vacher
Life of this patent
Estimating the term…
Abstract
This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase.
Claims20
A compound of formula I ##STR36## wherein R.sup.1 is optionally substituted lower alkyl;
- R.sup.2 is C.sub.3 -C.sub.15 alkyl, cycloalkyl substituted or halo substituted alkyl optionally substituted alkenyl, optionally substituted cycloalkyl, optionally substituted cycloalkenyl, optionally substituted or oxidized cyclothioalklyl, or optionally substituted or oxidized cyclothioalkenyl;
- R.sup.3 is optionally substituted aryl or optionally substituted heteroaryl;
- Z, Z.sup.1 and Z.sup.2 are independently oxygen or sulfur,
- Z.sup.3 is --CX.sub.2 --O--, SOCH.sub.2 --, SO.sub.2 CH.sub.2 --, --O--CX.sub.2 --, --O--CZ--, --N=N--, --NH--SO.sub.2 --, --CZ--CZ--NH--, --NH--CO--O--, --O--CO--NH-- or --NH--CO--NH--;
- and
- X is halo, or
- an N-oxide thereof or a pharmaceutically acceptable salt thereof,
- provided that when Z.sup.3 is --N=N--:
- R.sup.3 is optionally substituted aryl and Z.sup.1 and Z.sup.2 are oxygen:
- then R.sup.2 is other than C.sub.3 -C.sub.15 alkyl.
Dependencies are inferred from the claim text.